Kingskin Salicylic Acid Wart Removal Recall Due to cGMP Deviations
Pharmadel, LLC is recalling Kingskin salicylic acid wart-removal solution due to cGMP manufacturing deviations. The recall affects 20,048 bottles distributed in Delaware.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall, and the source text states no illnesses or injuries have been reported. The hazard is a manufacturing deviation without evidence of actual harm, placing it in the Moderate category.
Plain-English summary
Pharmadel, LLC is recalling Kingskin (Salicylic Acid), a topical over-the-counter drug product used for the removal of common warts. The product is a 0.50 fl oz (15 mL) liquid solution bearing NDC 55758-409-15 and distributed from the company's facility in New Castle, Delaware.
The recall was initiated due to current good manufacturing practice (cGMP) deviations. This is a voluntary, firm-initiated recall.
The affected product consists of 20,048 bottles distributed in Delaware. Affected lot numbers and expiration dates are: KSE-01 (EXP: OCT 26) and KSE-02 (EXP: FEB 27).
Consumers who have purchased this product should stop use. Consult with a pharmacist or healthcare provider with questions about alternative wart-removal treatments.
The recalled product
- Product
- KINGSKIN (SALICYLIC ACID)
- Brand
- KINGSKIN
- Manufacturer
- Pharmadel, LLC
- Category
- Drug — Topical OTC
- Affected units
- 20,048
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot
- expiry: KSE-01
- EXP: OCT 26
- KSE-02
- EXP: FEB 27
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 6 recalled by Pharmadel, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Pharmadel, LLC
See all →- ModerateDoloDent Maximum Strength Toothache Drops Recalled for cGMP Deviations
FDA (Drugs) · 2025-04-30
- ModerateUrodel Homeopathic Urinary Tract Infection Relief Tablets Recalled
FDA (Drugs) · 2025-04-30
- ModerateRapidol Arnica Gel topical homeopathic medicine recalled for manufacturing violations
FDA (Drugs) · 2025-04-30
- ModerateDoloEar Homeopathic Earache Drops Recalled for cGMP Deviations
FDA (Drugs) · 2025-04-30
- ModerateRapidol Arnica Tablets recalled due to manufacturing deviations
FDA (Drugs) · 2025-04-30
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateKingskin SacaCallos salicylic acid solution recalled for manufacturing deviations
FDA (Drugs) · 2025-05-28
- ModerateKOFAL Original Pain Relieving Ointment Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
- LowValeant Recalls CLENZIderm M.D. Pore Therapy Salicylic Acid Acne Treatment
FDA (Drugs) · 2017-04-26
- ModerateKOFAL Methyl Salicylate External Analgesic Ointment Recall
FDA (Drugs) · 2025-05-28
- ModerateRapidol Triple Antibiotic Ointment Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateMilbar Recalls Willa Clear Skin Salicylic Acid Tubes Due to GMP Deviations
FDA (Drugs) · 2020-11-25